BMO Capital Reiterates Outperform Rating, $780 Price Target on Regeneron Pharma (REGN) Following Checkmate (CMPI) Acquisition Apr 19, 2022 08:48AM
UPDATE: BMO Capital Starts Checkmate Pharmaceuticals (CMPI) at Outperform Sep 1, 2020 05:02AM
Checkmate Pharmaceuticals (CMPI) IPO Opens Modestly Lower Aug 7, 2020 12:05PM
Checkmate Pharmaceuticals (CMPI) IPO prices at $15 Aug 7, 2020 06:38AM
Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering Aug 6, 2020 09:18PM


Aug 6, 2020 09:17PM Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering